TTP
First Line Chemotherapy + T Fifty-six Her 2 neu+ patients received chemotherapy as first line metastatic treatment, n=12 without H, n=44 with H. Docetaxel/Carbo (DC+T) (n=21) was the most heavily utilized chemotherapy regimen with TTP 13.5 months and minimal toxicity.